ICD-10 Code D89.839 | Cytokine release syndrome, grade unspecified Symptoms, Diagnosis, Billing

Cytokine release syndrome, grade unspecified, is a systemic inflammatory response triggered by various factors, including infections, autoimmune diseases, and certain therapies such as monoclonal antibodies. This condition is clinically significant due to its potential to cause severe complications, including multi-organ failure. The ICD-10 Code D89.839 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.

What is ICD-10 Code D89.839 for Cytokine release syndrome, grade unspecified?

ICD-10 Code D89.839 represents Cytokine release syndrome, grade unspecified, a condition characterized by an excessive immune response leading to systemic inflammation. This syndrome can arise from various underlying diseases or complications, particularly in patients undergoing immunotherapy. The code should be used in clinical documentation and billing when the syndrome is identified, but the specific grade of severity is not determined.

ICD-10 Code D89.839 – Clinical Definition and Explanation of Cytokine release syndrome, grade unspecified

Cytokine release syndrome, grade unspecified, is caused by an overproduction of cytokines, often in response to infections, malignancies, or therapeutic interventions. It can progress rapidly, leading to significant morbidity and necessitating prompt medical attention.

Key Clinical Features:

• Fever and chills
• Hypotension or shock
• Respiratory distress
• Multi-organ dysfunction

ICD-10 Code D89.839 for Cytokine release syndrome, grade unspecified – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code D89.839 is utilized to document the presence of cytokine release syndrome, capturing symptoms, assessments, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code D89.839 for Cytokine release syndrome, grade unspecified Mean in SOAP Notes?

ICD-10 Code D89.839 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of cytokine release syndrome. This code is essential for ensuring continuity of care, supporting billing processes, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code D89.839 – Cytokine release syndrome, grade unspecified

Cytokine release syndrome often requires urgent medical intervention, including hospitalization for monitoring and treatment.

Antibiotic Therapy:

• Not applicable unless an infectious etiology is identified; consider broad-spectrum antibiotics if infection is suspected.
• Empirical therapy may include piperacillin-tazobactam or cefepime.
• Duration typically ranges from 7 to 14 days, depending on clinical response.

Supportive Care:

• Fluid resuscitation to manage hypotension.
• Oxygen therapy for respiratory distress.
• Monitoring and management of organ function.

Infection Control:

• Implement standard precautions to prevent transmission.
• Isolate patients with suspected infectious causes.
• Monitor for outbreaks in healthcare settings.

How to Document Symptoms of Cytokine release syndrome, grade unspecified (ICD-10 D89.839) in SOAP Notes

Subjective:

• Patient reports fever and chills over the past 24 hours.
• History of recent immunotherapy treatment.
• Complaints of shortness of breath and fatigue.

Objective:

• Vital signs: Temperature 102°F, BP 80/50 mmHg, HR 120 bpm.
• Respiratory rate: 28 breaths per minute, oxygen saturation 88% on room air.
• Physical exam reveals tachycardia and decreased breath sounds bilaterally.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Cytokine release syndrome, grade unspecified (ICD-10 Code D89.839)

Assessment:

• Cytokine release syndrome, grade unspecified, likely secondary to recent immunotherapy.
• ICD-10 Code D89.839.

Plan:

• Initiate IV fluid resuscitation and monitor vital signs closely.
• Consider corticosteroids if severe symptoms persist.
• Educate patient on signs of worsening condition and when to seek immediate care.
• Schedule follow-up in 48 hours or sooner if symptoms escalate.

Treatment & Plan Section for ICD-10 Code D89.839 – Cytokine release syndrome, grade unspecified

• Administer corticosteroids as indicated for severe inflammation.
• Implement lifestyle modifications to reduce stress and improve overall health.
• Monitor vital signs and organ function regularly.
• Follow up with laboratory tests to assess cytokine levels and organ function.

Using ICD-10 Code D89.839 for Cytokine release syndrome, grade unspecified in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in the Subjective (S) and Objective (O) sections.
• Use the code in conjunction with other relevant codes for comprehensive billing.
• Align treatment plans with clinical guidelines to support justified billing.
• Document any complications or comorbidities that may affect treatment and billing.

Related ICD-10 Codes Often Used with Cytokine release syndrome, grade unspecified

• D89.84 – Cytokine release syndrome, grade 3-4

ICD-10 Code D89.839 in Medical Billing and Insurance for Cytokine release syndrome, grade unspecified

ICD-10 Code D89.839 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.

Billing Notes:

• Document all relevant clinical findings and treatments to support the ICD-10 claim.
• Use the code in appropriate settings, including inpatient and outpatient care.
• Ensure that key chart elements, such as vital signs and treatment plans, are clearly recorded.

Common CPT Pairings: